Tighter Drug-Discount Rules Loom After 340B Report

Law360, New York (February 06, 2014, 7:49 PM ET) -- A new inspector general’s report is handing drugmakers fresh ammunition to argue that hospitals and clinics are abusing a multibillion-dollar drug-discount program known as 340B, putting pressure on the Obama administration to rein in health care providers in an upcoming rule designed to clarify the program's policies.

The report issued Wednesday was a detailed examination of compliance with 340B guidelines, and it sparked criticism by finding that some providers have been charging uninsured patients the full price of drugs and pocketing discounts for themselves.

“It’s unacceptable...
To view the full article, register now.